Europe — EMA

Ostiral (Raloxifene Hydrochloride)

Raloxifene Hydrochloride, the active ingredient in Ostiral, is a selective estrogen receptor modulator presented as a unknown/unknown for oral use. It treats osteoporosis in postmenopausal women.

Raloxifene Hydrochloride

Request sourcing

Pack/s

What is Raloxifene Hydrochloride?

Raloxifene Hydrochloride, the active ingredient in Ostiral, is a selective estrogen receptor modulator presented as a unknown/unknown for oral use. It treats osteoporosis in postmenopausal women. GNH USA supplies Ostiral as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ostiral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Raloxifene Hydrochloride used for?

Ostiral is a selective estrogen receptor modulator that works ...

What are the side effects of Raloxifene Hydrochloride?

Common

What precautions apply to Raloxifene Hydrochloride?

****

What does Raloxifene Hydrochloride interact with?

****

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →